EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease

Rishi Chowdhary, Manjeet Kumar Goyal, Megh Patel, Rahul Chowdhary, Kirti Arora, Varun Mehta, Akash Batta, Omesh Goyal, Ashita Rukmini Vuthaluru

Frontiers in Epidemiology · 11.06.2026 · 6

DOI: 10.3389/fepid.2026.1779600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Epidemiology, online erschienen am 11.06.2026. Verfasst von Rishi Chowdhary und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, United States. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aim Sarcopenia is increasingly recognized as a clinically relevant comorbidity in metabolic dysfunction–associated steatotic liver disease (MASLD), yet its epidemiology and prognostic implications in non-cirrhotic disease remain incompletely characterized. We aimed to evaluate temporal trends in the incidence and prevalence of sarcopenia among patients with MASLD and to assess its association with hepatic and cardiovascular outcomes.

Methods

We conducted a retrospective longitudinal cohort study of adults with MASLD diagnosed between 2005 and 2024 using a large, nationwide electronic health record network. Annual incidence and prevalence of sarcopenia were examined over time. Non-cirrhotic MASLD patients with sarcopenia were compared with non-sarcopenic controls using 1:1 propensity score matching to balance demographic characteristics, metabolic comorbidities, cardiovascular risk factors, and medication use. Hepatic and cardiovascular outcomes were evaluated using Kaplan–Meier analyses and Cox proportional hazards models.

Results

Among 1,232,337 patients with MASLD, 714 had documented sarcopenia. Both incidence and prevalence of sarcopenia increased steadily over the study period, with comparable trends across sexes. After propensity score matching, sarcopenia was associated with significantly higher odds of cirrhosis (OR 4.46), hepatic decompensation (OR 5.18), and all-cause mortality (OR 2.36). Sarcopenic MASLD patients also demonstrated increased risk of major adverse cardiovascular events, including heart failure, ischemic heart disease, atrial fibrillation, cerebrovascular events, and thrombotic disorders. On time-to-event analysis, sarcopenia independently predicted hepatic outcomes (HR 5.03) and cardiovascular outcomes (HR 2.24).

Conclusion

Sarcopenia is an increasingly prevalent condition in MASLD and a powerful independent predictor of adverse hepatic and cardiovascular outcomes in non-cirrhotic disease. These findings underscore the importance of early identification and targeted management of sarcopenia to improve long-term outcomes in MASLD.

Schlagwörter

Stichwörter der Autor:innen

ASCVDCVD (cardio vascular disease)MASLDhepatologicsarcopeniastroke

Autor:innen und Institutionen

  • Department of Pediatrics, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, United States.
  • Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, United States.
  • Department of Internal Medicine, B. J. Medical College, Ahmedabad, India.
  • Department of Internal Medicine, Cleveland Clinic Main Campus, Cleveland, OH, United States.
  • Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India.
  • Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, India.

Zitieren

APA

Chowdhary, R., Goyal, M. K., Patel, M., Chowdhary, R., Arora, K., Mehta, V., Batta, A., Goyal, O., & Vuthaluru, A. R. (2026). Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease. Frontiers in Epidemiology, 6. https://doi.org/10.3389/fepid.2026.1779600

Vancouver

Chowdhary R, Goyal MK, Patel M, Chowdhary R, Arora K, Mehta V, et al. Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease. Frontiers in Epidemiology. 2026;6. doi:10.3389/fepid.2026.1779600

BibTeX
@article{Chowdhary2026,
  author = {Chowdhary, Rishi and Goyal, Manjeet Kumar and Patel, Megh and Chowdhary, Rahul and Arora, Kirti and Mehta, Varun and Batta, Akash and Goyal, Omesh and Vuthaluru, Ashita Rukmini},
  title = {Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunction–associated steatotic liver disease},
  journal = {Frontiers in Epidemiology},
  year = {2026},
  volume = {6},
  doi = {10.3389/fepid.2026.1779600}
}
Kostenlos starten →